Quinazolin-derived myeloperoxidase inhibitor suppresses influenza A virus-induced reactive oxygen species, pro-inflammatory mediators and improves cell survival.
Superoxide radicals and other reactive oxygen species (ROS) are implicated in influenza A virus-induced inflammation. In this in vitro study, we evaluated the effects of TG6-44, a novel quinazolin-derived myeloperoxidase-specific ROS inhibitor, on influenza A virus (A/X31) infection using THP-1 lung...
Guardado en:
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/80b3ccda96934ff1811aa0a4c2c44104 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:80b3ccda96934ff1811aa0a4c2c44104 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:80b3ccda96934ff1811aa0a4c2c441042021-12-02T20:06:51ZQuinazolin-derived myeloperoxidase inhibitor suppresses influenza A virus-induced reactive oxygen species, pro-inflammatory mediators and improves cell survival.1932-620310.1371/journal.pone.0254632https://doaj.org/article/80b3ccda96934ff1811aa0a4c2c441042021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0254632https://doaj.org/toc/1932-6203Superoxide radicals and other reactive oxygen species (ROS) are implicated in influenza A virus-induced inflammation. In this in vitro study, we evaluated the effects of TG6-44, a novel quinazolin-derived myeloperoxidase-specific ROS inhibitor, on influenza A virus (A/X31) infection using THP-1 lung monocytic cells and freshly isolated peripheral blood mononuclear cells (PBMC). TG6-44 significantly decreased A/X31-induced ROS and virus-induced inflammatory mediators in THP-1 cells (IL-6, IFN-γ, MCP-1, TNF-α, MIP-1β) and in human PBMC (IL-6, IL-8, TNF-α, MCP-1). Interestingly, TG6-44-treated THP-1 cells showed a decrease in percent cells expressing viral nucleoprotein, as well as a delay in translocation of viral nucleoprotein into the nucleus. Furthermore, in influenza A virus-infected cells, TG6-44 treatment led to suppression of virus-induced cell death as evidenced by decreased caspase-3 activation, decreased proportion of Annexin V+PI+ cells, and increased Bcl-2 phosphorylation. Taken together, our results demonstrate the anti-inflammatory and anti-infective effects of TG6-44.Juan A De La CruzThota GaneshBecky A DieboldWeiping CaoAmelia HofstetterNeetu SinghAmrita KumarJames McCoyPriya RanjanSusan M E SmithSuryaprakash SambharaJ David LambethShivaprakash GangappaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 7, p e0254632 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Juan A De La Cruz Thota Ganesh Becky A Diebold Weiping Cao Amelia Hofstetter Neetu Singh Amrita Kumar James McCoy Priya Ranjan Susan M E Smith Suryaprakash Sambhara J David Lambeth Shivaprakash Gangappa Quinazolin-derived myeloperoxidase inhibitor suppresses influenza A virus-induced reactive oxygen species, pro-inflammatory mediators and improves cell survival. |
description |
Superoxide radicals and other reactive oxygen species (ROS) are implicated in influenza A virus-induced inflammation. In this in vitro study, we evaluated the effects of TG6-44, a novel quinazolin-derived myeloperoxidase-specific ROS inhibitor, on influenza A virus (A/X31) infection using THP-1 lung monocytic cells and freshly isolated peripheral blood mononuclear cells (PBMC). TG6-44 significantly decreased A/X31-induced ROS and virus-induced inflammatory mediators in THP-1 cells (IL-6, IFN-γ, MCP-1, TNF-α, MIP-1β) and in human PBMC (IL-6, IL-8, TNF-α, MCP-1). Interestingly, TG6-44-treated THP-1 cells showed a decrease in percent cells expressing viral nucleoprotein, as well as a delay in translocation of viral nucleoprotein into the nucleus. Furthermore, in influenza A virus-infected cells, TG6-44 treatment led to suppression of virus-induced cell death as evidenced by decreased caspase-3 activation, decreased proportion of Annexin V+PI+ cells, and increased Bcl-2 phosphorylation. Taken together, our results demonstrate the anti-inflammatory and anti-infective effects of TG6-44. |
format |
article |
author |
Juan A De La Cruz Thota Ganesh Becky A Diebold Weiping Cao Amelia Hofstetter Neetu Singh Amrita Kumar James McCoy Priya Ranjan Susan M E Smith Suryaprakash Sambhara J David Lambeth Shivaprakash Gangappa |
author_facet |
Juan A De La Cruz Thota Ganesh Becky A Diebold Weiping Cao Amelia Hofstetter Neetu Singh Amrita Kumar James McCoy Priya Ranjan Susan M E Smith Suryaprakash Sambhara J David Lambeth Shivaprakash Gangappa |
author_sort |
Juan A De La Cruz |
title |
Quinazolin-derived myeloperoxidase inhibitor suppresses influenza A virus-induced reactive oxygen species, pro-inflammatory mediators and improves cell survival. |
title_short |
Quinazolin-derived myeloperoxidase inhibitor suppresses influenza A virus-induced reactive oxygen species, pro-inflammatory mediators and improves cell survival. |
title_full |
Quinazolin-derived myeloperoxidase inhibitor suppresses influenza A virus-induced reactive oxygen species, pro-inflammatory mediators and improves cell survival. |
title_fullStr |
Quinazolin-derived myeloperoxidase inhibitor suppresses influenza A virus-induced reactive oxygen species, pro-inflammatory mediators and improves cell survival. |
title_full_unstemmed |
Quinazolin-derived myeloperoxidase inhibitor suppresses influenza A virus-induced reactive oxygen species, pro-inflammatory mediators and improves cell survival. |
title_sort |
quinazolin-derived myeloperoxidase inhibitor suppresses influenza a virus-induced reactive oxygen species, pro-inflammatory mediators and improves cell survival. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2021 |
url |
https://doaj.org/article/80b3ccda96934ff1811aa0a4c2c44104 |
work_keys_str_mv |
AT juanadelacruz quinazolinderivedmyeloperoxidaseinhibitorsuppressesinfluenzaavirusinducedreactiveoxygenspeciesproinflammatorymediatorsandimprovescellsurvival AT thotaganesh quinazolinderivedmyeloperoxidaseinhibitorsuppressesinfluenzaavirusinducedreactiveoxygenspeciesproinflammatorymediatorsandimprovescellsurvival AT beckyadiebold quinazolinderivedmyeloperoxidaseinhibitorsuppressesinfluenzaavirusinducedreactiveoxygenspeciesproinflammatorymediatorsandimprovescellsurvival AT weipingcao quinazolinderivedmyeloperoxidaseinhibitorsuppressesinfluenzaavirusinducedreactiveoxygenspeciesproinflammatorymediatorsandimprovescellsurvival AT ameliahofstetter quinazolinderivedmyeloperoxidaseinhibitorsuppressesinfluenzaavirusinducedreactiveoxygenspeciesproinflammatorymediatorsandimprovescellsurvival AT neetusingh quinazolinderivedmyeloperoxidaseinhibitorsuppressesinfluenzaavirusinducedreactiveoxygenspeciesproinflammatorymediatorsandimprovescellsurvival AT amritakumar quinazolinderivedmyeloperoxidaseinhibitorsuppressesinfluenzaavirusinducedreactiveoxygenspeciesproinflammatorymediatorsandimprovescellsurvival AT jamesmccoy quinazolinderivedmyeloperoxidaseinhibitorsuppressesinfluenzaavirusinducedreactiveoxygenspeciesproinflammatorymediatorsandimprovescellsurvival AT priyaranjan quinazolinderivedmyeloperoxidaseinhibitorsuppressesinfluenzaavirusinducedreactiveoxygenspeciesproinflammatorymediatorsandimprovescellsurvival AT susanmesmith quinazolinderivedmyeloperoxidaseinhibitorsuppressesinfluenzaavirusinducedreactiveoxygenspeciesproinflammatorymediatorsandimprovescellsurvival AT suryaprakashsambhara quinazolinderivedmyeloperoxidaseinhibitorsuppressesinfluenzaavirusinducedreactiveoxygenspeciesproinflammatorymediatorsandimprovescellsurvival AT jdavidlambeth quinazolinderivedmyeloperoxidaseinhibitorsuppressesinfluenzaavirusinducedreactiveoxygenspeciesproinflammatorymediatorsandimprovescellsurvival AT shivaprakashgangappa quinazolinderivedmyeloperoxidaseinhibitorsuppressesinfluenzaavirusinducedreactiveoxygenspeciesproinflammatorymediatorsandimprovescellsurvival |
_version_ |
1718375313976590336 |